Can GLP-1 agonists help in heart failure and severe obesity? Elizabeth Tracey reports

About this episode

The episode discusses the relationship between severe obesity and a type of heart failure, exploring the potential role of GLP-1 agonists in treatment.

There’s a relationship between severe obesity and one type of heart failure, and it looks like it’s mediated by adding more phosphate groups, a process known as phosphorylation, to proteins in heart muscle cells, specifically to units within the muscle … Can GLP-1 agonists help in heart failure and severe obesity? Elizabeth Tracey reports Read More »

People in this episode

Host: Elizabeth Tracey

Topics covered

• heart failure
• severe obesity
• GLP-1 agonists
• phosphorylation
• health
• medicine

Keywords

• GLP-1 agonists
• heart failure
• severe obesity
• phosphorylation
• health news

Mentioned in this episode

Organizations: Johns Hopkins Medicine

Products: GLP-1 agonists

More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts

• An AI model may help predict who is more likely to develop pancreas cancer, Elizabeth Tracey reports · June 11, 2026 · 1 min
• Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports · June 11, 2026 · 1 min
• Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports · June 11, 2026 · 1 min
• What accounts for increases in colorectal cancer among younger people? Elizabeth Tracey reports · June 11, 2026 · 1 min
• A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports · June 11, 2026 · 1 min
• A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports · June 8, 2026 · 1 min